Preparation for marrow transplantation in Hodgkin's and non-Hodgkin's lymphoma using Bu/CY
Avalos, B.R.; Klein, J.L.; Kapoor, N.; Tutschka, P.J.; Klein, J.P.; Copelan, E.A.
Bone Marrow Transplantation 12(2): 133-138
1993
ISSN/ISBN: 0268-3369 PMID: 8401359 Document Number: 411401
The results of autologous and allogeneic BMT in 44 patients with Hodgkin's or non-Hodgkin's lymphomas who received preparative therapy consisting of busulfan 16 mg/kg and cyclophosphamide 120 mg/kg are presented. Sixteen patients are surviving free of disease between 8 months and 6 years after transplantation. Thirteen patients either did not attain complete remission or experienced a recurrence of their disease. Fifteen patients died from treatment-related complications. Karnofsky score < or = 70, lactate dehydrogenase greater than twice normal and the development of hepatic veno-occlusive disease were associated with failure to achieve lymphoma-free survival.